MKS Instruments (MKSI) Tops Q2 EPS by 46c; offers guidance

MKS Instruments (NASDAQ: MKSI) reported Q2 EPS of $1.53, $0.46 better than the analyst estimate of $1.07. Revenue for the quarter came in at $887 million versus the consensus estimate of $866.38 million.

GUIDANCE:

MKS Instruments sees Q3 2024 EPS of $1.43, plus or minus $0.28, versus the consensus of $1.33. MKS Instruments sees Q3 2024 revenue of $870 million, plus or minus $40 million, versus the consensus of $893.2 million.

For earnings history and earnings-related data on MKS Instruments (MKSI) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Fed policy stance keeps Treasury yields high, says Citadel Securities
• Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker